Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 6, 2022; 10(7): 2127-2137
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2127
Table 1 Characteristics of hematological patients
Diagnosis
Patients with hematological diseases (n = 207)
Normal controls (n = 26)
P value
Local infection
Sepsis
No infection
Sex, n (%)0.255
Female34 (50.7)58 (64.4)26 (52.0)13 (50.0)
Male33 (49.3)32 (35.6)24 (48.0)13 (50.0)
Age, median [range], yr60 [14-86]60 [18-84]60 [21-88]46 [22-76]0.726
WBC, median [range] (× 109/L)3.7 [0.30-136.0]2.55 [0.30-161.0]3.4 [0.70-20.4]0.090
ANC, median [range] (× 109/L)2.31 [0.00-45.80]0.745 [0.00-39.00]2.1 [0.10-13.59]0.013
RBC, median [range] (× 1012/L)2.53 [1.15-4.87]2.40 [1.13-4.51]3.05 [1.68-4.62]< 0.001
PLT, median [range] (× 109/L)56 [6-456]34 [1-462]133 [8-517]< 0.001
Table 2 Infection characteristics in hematological patients
Infection sitesHematological patients with local infection (n = 67)
Hematological patients with sepsis (n = 90)
Clinical diagnosis (n = 55)
Positive culture of secretions (n = 11)
Positive blood culture (n = 1)
Clinical diagnosis (n = 54)
Positive culture of secretions (n = 26)
Positive blood culture (n = 10)
Upper respiratory tract infection201-123541
Lung infection271613151465
Suppurative tonsillitis---12-
Oral infections22-112
Cholecystitis---2--
Appendicitis2-----
Perianal infection---27--
Skin and soft tissue infection221-121
Urinary tract infection-1-482-
Unknown infection site2----1
Table 3 Diagnostic value of the neutrophil CD64 index, procalcitonin, and high-sensitivity C-reactive protein for early sepsis in hematological patients
Indicator
AUC
Best cutoff
Sensitivity
Specificity
Likelihood ratio
Positive
Negative
nCD64 index77.7%1.46582.3%67.2%2.510.26
PCT (ng/mL)73.5%0.17567.8%71.6%2.390.45
hs-CRP (mg/L)67.0%69.854.4%74.6%2.180.60